Cerity Partners
IRWD icon

Cerity Partners’s Ironwood Pharmaceuticals IRWD Stock Holding History

Cerity Partners’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.29M Buy
368,370
+29,858
+9% +$122K ﹤0.01% 1718
2025
Q4 		$1.14M Sell
338,512
-536
-0.2% -$1.39K ﹤0.01% 1651
2025
Q3 		$444K Sell
339,048
-641
-0.2% -$663 ﹤0.01% 2051
2025
Q2 		$244K Buy
339,689
+243,211
+252% +$191K ﹤0.01% 2256
2025
Q1 		$142K Buy
+96,478
New +$230K ﹤0.01% 2273
2024
Q2 		– Sell
-10,485
Closed -$91.3K – 2308
2024
Q1 		$91.3K Buy
+10,485
New +$127K ﹤0.01% 2210

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Cerity Partners's IRWD Position: Q1 2026 in Review

Cerity Partners increased its Ironwood Pharmaceuticals (IRWD) stake by 8.8% in Q1 2026, buying an estimated $122K and bringing the position to 368,370 shares worth $1.29M. The position accounts for ﹤0.01% of the portfolio, ranked #1718.

Cerity Partners first reported a position in IRWD in Q1 2024 and has held it in 6 quarters since. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Cerity Partners held 368,370 shares of Ironwood Pharmaceuticals worth $1.29M as of Q1 2026.
  • Cerity Partners bought 29,858 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $122K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Cerity Partners's portfolio in Q1 2026, its #1718 holding.
  • Cerity Partners first reported a position in Ironwood Pharmaceuticals in Q1 2024 and has held it in 6 quarters since.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.